Loading…
Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens
Disseminated adenovirus (ADV) infection is a fatal complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), however, it is rare following autologous peripheral blood stem cell transplantation (auto-PBSCT) or chemotherapy alone. A 66-year-old Japanese female with relapsed and r...
Saved in:
Published in: | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019-05, Vol.25 (5), p.371-375 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3 |
---|---|
cites | cdi_FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3 |
container_end_page | 375 |
container_issue | 5 |
container_start_page | 371 |
container_title | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |
container_volume | 25 |
creator | Yasuda, Shunichiro Najima, Yuho Konishi, Tatsuya Yamada, Yuta Takezaki, Toshiaki Kurosawa, Shuhei Sakaguchi, Masahiro Harada, Kaito Yoshioka, Kosuke Igarashi, Aiko Inamoto, Kyoko Toya, Takashi Kobayashi, Takeshi Doki, Noriko Kakihana, Kazuhiko Sakamaki, Hisashi Sekiya, Noritaka Ohashi, Kazuteru |
description | Disseminated adenovirus (ADV) infection is a fatal complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), however, it is rare following autologous peripheral blood stem cell transplantation (auto-PBSCT) or chemotherapy alone.
A 66-year-old Japanese female with relapsed and refractory multiple myeloma (RRMM) received auto-PBSCT, achieving partial response. To obtain a greater response, pomalidomide/dexamethasone was started on day 28 after auto-PBSCT, but was stopped on day 41 due to thrombocytopenia, fever, and gross hematuria. Additionally, she complained of abdominal pain on day 46. Blood tests revealed elevation of transaminases and alkaline phosphatase. There was no evidence of bacterial or fungal infections or progression of MM. ADV titer in urine and serum were 3.41 × 105 copies/mL and 6.76 × 103 copies/mL, respectively. CT scans revealed cystitis, urethritis, and peritonitis. Since more than two organs were infected with ADV, she was diagnosed with disseminated ADV disease. After 5 weeks of supportive care, all symptoms resolved. ADV titer decreased to 5.90 × 102 copies/mL in urine and became negative in serum on day 80. However, she succumbed to the MM a little more than a month later.
Disseminated ADV infection can occur even in non-allogeneic transplant settings, such as in severely immunocompromised patients with MM who receive auto-PBSCT and repeated salvage therapies. Although it is a rare event, the mortality rate of this disease is very high, and hence, early diagnosis and interventions are needed in suspected cases. |
doi_str_mv | 10.1016/j.jiac.2018.11.011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179351533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1341321X18304690</els_id><sourcerecordid>2179351533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3</originalsourceid><addsrcrecordid>eNp9kc2O1DAQhCMEYpeFF-CAfOSSrNtOJhmJC9rlT1qJC0jcrJ64k_XIP8F2BubZeDk8zMKRk1tWVbWqv6p6CbwBDpvrfbM3ODaCw9AANBzgUXUJrezrvh_44zLLFmop4NtF9SylPefQd8PwtLqQfNOKvheX1a9bkxI54zGTZqjJh4OJa2LGTzRmE3yZGLIFsyGf2Q-T71kki0sq-khTxDGHeGRutdkslpg7kg0O2eo1xTkYPzNcc7BhDiU2ZXJsJGtZjujTYtFn_LMGvWZLMVqjgzOarjX9REf5HlPwxLB40R5wprJ1No58el49mdAmevHwXlVf37_7cvOxvvv84dPN27t6lAPP9WYr-1YMiHwU5aODcQck-NBuygU6bFs5CQLY0o4mQJwm3g7dZreVHDoukORV9fqcu8TwfaWUlTPp1AE9lU5KQL-VHXRSFqk4S8cYUirnUUs0DuNRAVcnaGqvTtDUCZoCUAVaMb16yF93jvQ_y19KRfDmLKDS8mAoqjQWGiNpEwskpYP5X_5vULyuWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179351533</pqid></control><display><type>article</type><title>Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens</title><source>ScienceDirect Journals</source><creator>Yasuda, Shunichiro ; Najima, Yuho ; Konishi, Tatsuya ; Yamada, Yuta ; Takezaki, Toshiaki ; Kurosawa, Shuhei ; Sakaguchi, Masahiro ; Harada, Kaito ; Yoshioka, Kosuke ; Igarashi, Aiko ; Inamoto, Kyoko ; Toya, Takashi ; Kobayashi, Takeshi ; Doki, Noriko ; Kakihana, Kazuhiko ; Sakamaki, Hisashi ; Sekiya, Noritaka ; Ohashi, Kazuteru</creator><creatorcontrib>Yasuda, Shunichiro ; Najima, Yuho ; Konishi, Tatsuya ; Yamada, Yuta ; Takezaki, Toshiaki ; Kurosawa, Shuhei ; Sakaguchi, Masahiro ; Harada, Kaito ; Yoshioka, Kosuke ; Igarashi, Aiko ; Inamoto, Kyoko ; Toya, Takashi ; Kobayashi, Takeshi ; Doki, Noriko ; Kakihana, Kazuhiko ; Sakamaki, Hisashi ; Sekiya, Noritaka ; Ohashi, Kazuteru</creatorcontrib><description>Disseminated adenovirus (ADV) infection is a fatal complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), however, it is rare following autologous peripheral blood stem cell transplantation (auto-PBSCT) or chemotherapy alone.
A 66-year-old Japanese female with relapsed and refractory multiple myeloma (RRMM) received auto-PBSCT, achieving partial response. To obtain a greater response, pomalidomide/dexamethasone was started on day 28 after auto-PBSCT, but was stopped on day 41 due to thrombocytopenia, fever, and gross hematuria. Additionally, she complained of abdominal pain on day 46. Blood tests revealed elevation of transaminases and alkaline phosphatase. There was no evidence of bacterial or fungal infections or progression of MM. ADV titer in urine and serum were 3.41 × 105 copies/mL and 6.76 × 103 copies/mL, respectively. CT scans revealed cystitis, urethritis, and peritonitis. Since more than two organs were infected with ADV, she was diagnosed with disseminated ADV disease. After 5 weeks of supportive care, all symptoms resolved. ADV titer decreased to 5.90 × 102 copies/mL in urine and became negative in serum on day 80. However, she succumbed to the MM a little more than a month later.
Disseminated ADV infection can occur even in non-allogeneic transplant settings, such as in severely immunocompromised patients with MM who receive auto-PBSCT and repeated salvage therapies. Although it is a rare event, the mortality rate of this disease is very high, and hence, early diagnosis and interventions are needed in suspected cases.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2018.11.011</identifier><identifier>PMID: 30642772</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenovirus infections ; Autologous stem cell transplantation ; Multiple myeloma ; Pomalidomide</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-05, Vol.25 (5), p.371-375</ispartof><rights>2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3</citedby><cites>FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3</cites><orcidid>0000-0001-8910-0021 ; 0000-0002-0765-4221</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30642772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yasuda, Shunichiro</creatorcontrib><creatorcontrib>Najima, Yuho</creatorcontrib><creatorcontrib>Konishi, Tatsuya</creatorcontrib><creatorcontrib>Yamada, Yuta</creatorcontrib><creatorcontrib>Takezaki, Toshiaki</creatorcontrib><creatorcontrib>Kurosawa, Shuhei</creatorcontrib><creatorcontrib>Sakaguchi, Masahiro</creatorcontrib><creatorcontrib>Harada, Kaito</creatorcontrib><creatorcontrib>Yoshioka, Kosuke</creatorcontrib><creatorcontrib>Igarashi, Aiko</creatorcontrib><creatorcontrib>Inamoto, Kyoko</creatorcontrib><creatorcontrib>Toya, Takashi</creatorcontrib><creatorcontrib>Kobayashi, Takeshi</creatorcontrib><creatorcontrib>Doki, Noriko</creatorcontrib><creatorcontrib>Kakihana, Kazuhiko</creatorcontrib><creatorcontrib>Sakamaki, Hisashi</creatorcontrib><creatorcontrib>Sekiya, Noritaka</creatorcontrib><creatorcontrib>Ohashi, Kazuteru</creatorcontrib><title>Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>Disseminated adenovirus (ADV) infection is a fatal complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), however, it is rare following autologous peripheral blood stem cell transplantation (auto-PBSCT) or chemotherapy alone.
A 66-year-old Japanese female with relapsed and refractory multiple myeloma (RRMM) received auto-PBSCT, achieving partial response. To obtain a greater response, pomalidomide/dexamethasone was started on day 28 after auto-PBSCT, but was stopped on day 41 due to thrombocytopenia, fever, and gross hematuria. Additionally, she complained of abdominal pain on day 46. Blood tests revealed elevation of transaminases and alkaline phosphatase. There was no evidence of bacterial or fungal infections or progression of MM. ADV titer in urine and serum were 3.41 × 105 copies/mL and 6.76 × 103 copies/mL, respectively. CT scans revealed cystitis, urethritis, and peritonitis. Since more than two organs were infected with ADV, she was diagnosed with disseminated ADV disease. After 5 weeks of supportive care, all symptoms resolved. ADV titer decreased to 5.90 × 102 copies/mL in urine and became negative in serum on day 80. However, she succumbed to the MM a little more than a month later.
Disseminated ADV infection can occur even in non-allogeneic transplant settings, such as in severely immunocompromised patients with MM who receive auto-PBSCT and repeated salvage therapies. Although it is a rare event, the mortality rate of this disease is very high, and hence, early diagnosis and interventions are needed in suspected cases.</description><subject>Adenovirus infections</subject><subject>Autologous stem cell transplantation</subject><subject>Multiple myeloma</subject><subject>Pomalidomide</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kc2O1DAQhCMEYpeFF-CAfOSSrNtOJhmJC9rlT1qJC0jcrJ64k_XIP8F2BubZeDk8zMKRk1tWVbWqv6p6CbwBDpvrfbM3ODaCw9AANBzgUXUJrezrvh_44zLLFmop4NtF9SylPefQd8PwtLqQfNOKvheX1a9bkxI54zGTZqjJh4OJa2LGTzRmE3yZGLIFsyGf2Q-T71kki0sq-khTxDGHeGRutdkslpg7kg0O2eo1xTkYPzNcc7BhDiU2ZXJsJGtZjujTYtFn_LMGvWZLMVqjgzOarjX9REf5HlPwxLB40R5wprJ1No58el49mdAmevHwXlVf37_7cvOxvvv84dPN27t6lAPP9WYr-1YMiHwU5aODcQck-NBuygU6bFs5CQLY0o4mQJwm3g7dZreVHDoukORV9fqcu8TwfaWUlTPp1AE9lU5KQL-VHXRSFqk4S8cYUirnUUs0DuNRAVcnaGqvTtDUCZoCUAVaMb16yF93jvQ_y19KRfDmLKDS8mAoqjQWGiNpEwskpYP5X_5vULyuWg</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Yasuda, Shunichiro</creator><creator>Najima, Yuho</creator><creator>Konishi, Tatsuya</creator><creator>Yamada, Yuta</creator><creator>Takezaki, Toshiaki</creator><creator>Kurosawa, Shuhei</creator><creator>Sakaguchi, Masahiro</creator><creator>Harada, Kaito</creator><creator>Yoshioka, Kosuke</creator><creator>Igarashi, Aiko</creator><creator>Inamoto, Kyoko</creator><creator>Toya, Takashi</creator><creator>Kobayashi, Takeshi</creator><creator>Doki, Noriko</creator><creator>Kakihana, Kazuhiko</creator><creator>Sakamaki, Hisashi</creator><creator>Sekiya, Noritaka</creator><creator>Ohashi, Kazuteru</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8910-0021</orcidid><orcidid>https://orcid.org/0000-0002-0765-4221</orcidid></search><sort><creationdate>20190501</creationdate><title>Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens</title><author>Yasuda, Shunichiro ; Najima, Yuho ; Konishi, Tatsuya ; Yamada, Yuta ; Takezaki, Toshiaki ; Kurosawa, Shuhei ; Sakaguchi, Masahiro ; Harada, Kaito ; Yoshioka, Kosuke ; Igarashi, Aiko ; Inamoto, Kyoko ; Toya, Takashi ; Kobayashi, Takeshi ; Doki, Noriko ; Kakihana, Kazuhiko ; Sakamaki, Hisashi ; Sekiya, Noritaka ; Ohashi, Kazuteru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenovirus infections</topic><topic>Autologous stem cell transplantation</topic><topic>Multiple myeloma</topic><topic>Pomalidomide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yasuda, Shunichiro</creatorcontrib><creatorcontrib>Najima, Yuho</creatorcontrib><creatorcontrib>Konishi, Tatsuya</creatorcontrib><creatorcontrib>Yamada, Yuta</creatorcontrib><creatorcontrib>Takezaki, Toshiaki</creatorcontrib><creatorcontrib>Kurosawa, Shuhei</creatorcontrib><creatorcontrib>Sakaguchi, Masahiro</creatorcontrib><creatorcontrib>Harada, Kaito</creatorcontrib><creatorcontrib>Yoshioka, Kosuke</creatorcontrib><creatorcontrib>Igarashi, Aiko</creatorcontrib><creatorcontrib>Inamoto, Kyoko</creatorcontrib><creatorcontrib>Toya, Takashi</creatorcontrib><creatorcontrib>Kobayashi, Takeshi</creatorcontrib><creatorcontrib>Doki, Noriko</creatorcontrib><creatorcontrib>Kakihana, Kazuhiko</creatorcontrib><creatorcontrib>Sakamaki, Hisashi</creatorcontrib><creatorcontrib>Sekiya, Noritaka</creatorcontrib><creatorcontrib>Ohashi, Kazuteru</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yasuda, Shunichiro</au><au>Najima, Yuho</au><au>Konishi, Tatsuya</au><au>Yamada, Yuta</au><au>Takezaki, Toshiaki</au><au>Kurosawa, Shuhei</au><au>Sakaguchi, Masahiro</au><au>Harada, Kaito</au><au>Yoshioka, Kosuke</au><au>Igarashi, Aiko</au><au>Inamoto, Kyoko</au><au>Toya, Takashi</au><au>Kobayashi, Takeshi</au><au>Doki, Noriko</au><au>Kakihana, Kazuhiko</au><au>Sakamaki, Hisashi</au><au>Sekiya, Noritaka</au><au>Ohashi, Kazuteru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>25</volume><issue>5</issue><spage>371</spage><epage>375</epage><pages>371-375</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>Disseminated adenovirus (ADV) infection is a fatal complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), however, it is rare following autologous peripheral blood stem cell transplantation (auto-PBSCT) or chemotherapy alone.
A 66-year-old Japanese female with relapsed and refractory multiple myeloma (RRMM) received auto-PBSCT, achieving partial response. To obtain a greater response, pomalidomide/dexamethasone was started on day 28 after auto-PBSCT, but was stopped on day 41 due to thrombocytopenia, fever, and gross hematuria. Additionally, she complained of abdominal pain on day 46. Blood tests revealed elevation of transaminases and alkaline phosphatase. There was no evidence of bacterial or fungal infections or progression of MM. ADV titer in urine and serum were 3.41 × 105 copies/mL and 6.76 × 103 copies/mL, respectively. CT scans revealed cystitis, urethritis, and peritonitis. Since more than two organs were infected with ADV, she was diagnosed with disseminated ADV disease. After 5 weeks of supportive care, all symptoms resolved. ADV titer decreased to 5.90 × 102 copies/mL in urine and became negative in serum on day 80. However, she succumbed to the MM a little more than a month later.
Disseminated ADV infection can occur even in non-allogeneic transplant settings, such as in severely immunocompromised patients with MM who receive auto-PBSCT and repeated salvage therapies. Although it is a rare event, the mortality rate of this disease is very high, and hence, early diagnosis and interventions are needed in suspected cases.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>30642772</pmid><doi>10.1016/j.jiac.2018.11.011</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-8910-0021</orcidid><orcidid>https://orcid.org/0000-0002-0765-4221</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-321X |
ispartof | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-05, Vol.25 (5), p.371-375 |
issn | 1341-321X 1437-7780 |
language | eng |
recordid | cdi_proquest_miscellaneous_2179351533 |
source | ScienceDirect Journals |
subjects | Adenovirus infections Autologous stem cell transplantation Multiple myeloma Pomalidomide |
title | Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T13%3A05%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disseminated%20adenovirus%20infection%20in%20a%20patient%20with%20relapsed%20refractory%20multiple%20myeloma%20undergoing%20autologous%20stem%20cell%20transplantation%20and%20pomalidomide/dexamethasone%20as%20salvage%20regimens&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Yasuda,%20Shunichiro&rft.date=2019-05-01&rft.volume=25&rft.issue=5&rft.spage=371&rft.epage=375&rft.pages=371-375&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2018.11.011&rft_dat=%3Cproquest_cross%3E2179351533%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c380t-6937428aa0c238051cb1e208467725a443f2e119ebef1aaff04856b9301502ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2179351533&rft_id=info:pmid/30642772&rfr_iscdi=true |